Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12388444rdf:typepubmed:Citationlld:pubmed
pubmed-article:12388444lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:12388444lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:12388444lifeskim:mentionsumls-concept:C1565860lld:lifeskim
pubmed-article:12388444lifeskim:mentionsumls-concept:C1705323lld:lifeskim
pubmed-article:12388444lifeskim:mentionsumls-concept:C0010692lld:lifeskim
pubmed-article:12388444lifeskim:mentionsumls-concept:C0042034lld:lifeskim
pubmed-article:12388444lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:12388444lifeskim:mentionsumls-concept:C1704259lld:lifeskim
pubmed-article:12388444lifeskim:mentionsumls-concept:C1705987lld:lifeskim
pubmed-article:12388444lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:12388444lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:12388444pubmed:issue2lld:pubmed
pubmed-article:12388444pubmed:dateCreated2003-1-16lld:pubmed
pubmed-article:12388444pubmed:abstractTextThe purpose of this study was to determine the role of cyclooxygenase-2 (COX-2) and its metabolites in lower urinary tract function after induction of acute (4 h), intermediate (48 h), or chronic (10 day) cyclophosphamide (CYP)-induced cystitis. Bladders were harvested from euthanized female rats for analyses. Conscious cystometry was used to assess the effects of a COX-2-specific inhibitor, 5,5-dimethyl-3-(3-fluorophenyl)-4-(4-methylsulfonyl)phenyl2(5H)-furanone (DFU, 5 mg/kg sc), a disubstituted furanone, in CYP-induced cystitis. COX-2 mRNA was increased in inflamed bladders after acute (12-fold) and chronic (9-fold) treatment. COX-2 protein expression in inflamed bladders paralleled COX-2 mRNA expression. Prostaglandin D2-methoxime expression in the bladder was significantly (P < or = 0.01) increased in acute (3-fold) and chronic (5.5-fold) cystitis. Prostaglandin E2 was significantly (P < or = 0.01) increased (2-fold) in the bladder with intermediate (1.7-fold) and chronic (2.6-fold) cystitis. COX-2-immunoreactive cell profiles were distributed throughout the inflamed bladder and coexpressed histamine immunoreactivity. Conscious cystometry in rats treated with CYP + DFU showed increased micturition intervals 4 and 48 h after CYP treatment and decreased intravesical pressures during filling and micturition compared with rats treated with CYP + vehicle. These studies suggest an involvement of urinary bladder COX-2 and its metabolites in altered micturition reflexes with CYP-induced cystitis.lld:pubmed
pubmed-article:12388444pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12388444pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12388444pubmed:languageenglld:pubmed
pubmed-article:12388444pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12388444pubmed:citationSubsetIMlld:pubmed
pubmed-article:12388444pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12388444pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12388444pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12388444pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12388444pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12388444pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12388444pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12388444pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12388444pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12388444pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12388444pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12388444pubmed:statusMEDLINElld:pubmed
pubmed-article:12388444pubmed:monthFeblld:pubmed
pubmed-article:12388444pubmed:issn0363-6119lld:pubmed
pubmed-article:12388444pubmed:authorpubmed-author:ZvaraPPlld:pubmed
pubmed-article:12388444pubmed:authorpubmed-author:VizzardM AMAlld:pubmed
pubmed-article:12388444pubmed:authorpubmed-author:MalleySSlld:pubmed
pubmed-article:12388444pubmed:authorpubmed-author:HuV YVYlld:pubmed
pubmed-article:12388444pubmed:authorpubmed-author:DattilioAAlld:pubmed
pubmed-article:12388444pubmed:authorpubmed-author:FolsomJ BJBlld:pubmed
pubmed-article:12388444pubmed:issnTypePrintlld:pubmed
pubmed-article:12388444pubmed:volume284lld:pubmed
pubmed-article:12388444pubmed:ownerNLMlld:pubmed
pubmed-article:12388444pubmed:authorsCompleteYlld:pubmed
pubmed-article:12388444pubmed:paginationR574-85lld:pubmed
pubmed-article:12388444pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:12388444pubmed:meshHeadingpubmed-meshheading:12388444...lld:pubmed
pubmed-article:12388444pubmed:meshHeadingpubmed-meshheading:12388444...lld:pubmed
pubmed-article:12388444pubmed:meshHeadingpubmed-meshheading:12388444...lld:pubmed
pubmed-article:12388444pubmed:meshHeadingpubmed-meshheading:12388444...lld:pubmed
pubmed-article:12388444pubmed:meshHeadingpubmed-meshheading:12388444...lld:pubmed
pubmed-article:12388444pubmed:meshHeadingpubmed-meshheading:12388444...lld:pubmed
pubmed-article:12388444pubmed:meshHeadingpubmed-meshheading:12388444...lld:pubmed
pubmed-article:12388444pubmed:meshHeadingpubmed-meshheading:12388444...lld:pubmed
pubmed-article:12388444pubmed:meshHeadingpubmed-meshheading:12388444...lld:pubmed
pubmed-article:12388444pubmed:meshHeadingpubmed-meshheading:12388444...lld:pubmed
pubmed-article:12388444pubmed:meshHeadingpubmed-meshheading:12388444...lld:pubmed
pubmed-article:12388444pubmed:meshHeadingpubmed-meshheading:12388444...lld:pubmed
pubmed-article:12388444pubmed:meshHeadingpubmed-meshheading:12388444...lld:pubmed
pubmed-article:12388444pubmed:meshHeadingpubmed-meshheading:12388444...lld:pubmed
pubmed-article:12388444pubmed:meshHeadingpubmed-meshheading:12388444...lld:pubmed
pubmed-article:12388444pubmed:meshHeadingpubmed-meshheading:12388444...lld:pubmed
pubmed-article:12388444pubmed:meshHeadingpubmed-meshheading:12388444...lld:pubmed
pubmed-article:12388444pubmed:meshHeadingpubmed-meshheading:12388444...lld:pubmed
pubmed-article:12388444pubmed:meshHeadingpubmed-meshheading:12388444...lld:pubmed
pubmed-article:12388444pubmed:meshHeadingpubmed-meshheading:12388444...lld:pubmed
pubmed-article:12388444pubmed:meshHeadingpubmed-meshheading:12388444...lld:pubmed
pubmed-article:12388444pubmed:year2003lld:pubmed
pubmed-article:12388444pubmed:articleTitleCOX-2 and prostanoid expression in micturition pathways after cyclophosphamide-induced cystitis in the rat.lld:pubmed
pubmed-article:12388444pubmed:affiliationDepartments of Neurology, Anatomy and Neurobiology, and Surgery, University of Vermont College of Medicine, Burlington, Vermont 05405, USA.lld:pubmed
pubmed-article:12388444pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12388444pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:12388444pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:29527entrezgene:pubmedpubmed-article:12388444lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:12388444lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12388444lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12388444lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12388444lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12388444lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12388444lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12388444lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12388444lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12388444lld:pubmed